IDEAS home Printed from https://ideas.repec.org/a/wsi/acsxxx/v18y2015i07n08ns0219525915500216.html
   My bibliography  Save this article

Dynamics In An Sir Model When Vaccination Demand Follows Prior Levels Of Disease Prevalence

Author

Listed:
  • JOHN C. ECKALBAR

    (Department of Economics, California State University, 1st and Normal Chico, CA 95926-0430, United States)

  • PETE TSOURNOS

    (Department of Economics, California State University, 1st and Normal Chico, CA 95926-0430, United States)

  • WALTER L. ECKALBAR

    (#x2020;Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, 1550, 4th Street, Bldg 19B, San Francisco CA 94158, United States)

Abstract

This paper investigates an susceptible, infectious, recovered (SIR) model with childhood vaccination demand modeled as a function of prior levels of disease prevalence. Stability conditions for endemic and disease-free equilibria are uncovered, and both Hopf bifurcations and chaos are found with certain constellations of parameter values. Policy interventions directed toward increasing vaccination are explored, and the implied magnitudes of the external benefit of vaccination are modeled.

Suggested Citation

  • John C. Eckalbar & Pete Tsournos & Walter L. Eckalbar, 2015. "Dynamics In An Sir Model When Vaccination Demand Follows Prior Levels Of Disease Prevalence," Advances in Complex Systems (ACS), World Scientific Publishing Co. Pte. Ltd., vol. 18(07n08), pages 1-27, November.
    • Handle: RePEc:wsi:acsxxx:v:18:y:2015:i:07n08:n:s0219525915500216
    DOI: 10.1142/S0219525915500216
    as

    Download full text from publisher

    File URL: http://www.worldscientific.com/doi/abs/10.1142/S0219525915500216
    Download Restriction: Access to full text is restricted to subscribers
    File URL: https://libkey.io/10.1142/S0219525915500216?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Gao, Shujing & Teng, Zhidong & Xie, Dehui, 2009. "Analysis of a delayed SIR epidemic model with pulse vaccination," Chaos, Solitons & Fractals, Elsevier, vol. 40(2), pages 1004-1011.
    2. Geoffard, Pierre-Yves & Philipson, Tomas, 1997. "Disease Eradication: Private versus Public Vaccination," American Economic Review, American Economic Association, vol. 87(1), pages 222-230, March.
    3. John Mullahy, 1999. "It'll only hurt a second? Microeconomic determinants of who gets flu shots," Health Economics, John Wiley & Sons, Ltd., vol. 8(1), pages 9-24, February.
    4. Tomas Philipson, 1996. "Private Vaccination and Public Health: An Empirical Examination for U.S. Measles," Journal of Human Resources, University of Wisconsin Press, vol. 31(3), pages 611-630.
    5. Carol Y. Lin, 2008. "Modeling Infectious Diseases in Humans and Animals by KEELING, M. J. and ROHANI, P," Biometrics, The International Biometric Society, vol. 64(3), pages 993-993, September.
    6. Nicole Radde, 2008. "The Effect Of Time Scale Differences And Time Delays On The Structural Stability Of Oscillations In A Two-Gene Network," Advances in Complex Systems (ACS), World Scientific Publishing Co. Pte. Ltd., vol. 11(03), pages 471-483.
    7. Canabarro, A.A. & Gléria, I.M. & Lyra, M.L., 2004. "Periodic solutions and chaos in a non-linear model for the delayed cellular immune response," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 342(1), pages 234-241.
    8. Joseph Cook & Marc Jeuland & Brian Maskery & Donald Lauria & Dipika Sur & John Clemens & Dale Whittington, 2009. "Using private demand studies to calculate socially optimal vaccine subsidies in developing countries," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 28(1), pages 6-28.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sarkar, Jayanta, 2022. "Do disease prevalence and severity drive COVID-19 vaccine demand?," Economic Analysis and Policy, Elsevier, vol. 75(C), pages 310-319.
    2. Battiston, Pietro & Gamba, Simona, 2021. "COVID-19: R0 is lower where outbreak is larger," Health Policy, Elsevier, vol. 125(2), pages 141-147.
    3. Barham, Tania & Maluccio, John A., 2009. "Eradicating diseases: The effect of conditional cash transfers on vaccination coverage in rural Nicaragua," Journal of Health Economics, Elsevier, vol. 28(3), pages 611-621, May.
    4. Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
    5. Graff Zivin, Joshua & Neidell, Matthew, 2009. "Days of haze: Environmental information disclosure and intertemporal avoidance behavior," Journal of Environmental Economics and Management, Elsevier, vol. 58(2), pages 119-128, September.
    6. Matthew Neidell, 2009. "Information, Avoidance Behavior, and Health: The Effect of Ozone on Asthma Hospitalizations," Journal of Human Resources, University of Wisconsin Press, vol. 44(2).
    7. Courtney J. Ward, 2009. "Influenza Immunization Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?," Working Papers daleconwp2010-01, Dalhousie University, Department of Economics.
    8. Courtney J. Ward, 2014. "Influenza Vaccination Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?," American Economic Journal: Applied Economics, American Economic Association, vol. 6(1), pages 38-72, January.
    9. Hirani, Jonas Lau-Jensen, 2021. "Inattention or reluctance? Parental responses to vaccination reminder letters," Journal of Health Economics, Elsevier, vol. 76(C).
    10. Robert Nuscheler & Kerstin Roeder, 2016. "To Vaccinate or to Procrastinate? That is the Prevention Question," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1560-1581, December.
    11. Troy Tassier & Philip Polgreen & Alberto Segre, 2015. "Vaccination Games with Peer Effects in a Heterogeneous Hospital Worker Population," Administrative Sciences, MDPI, vol. 5(1), pages 1-25, January.
    12. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
    13. Humlum, Maria Knoth & Morthorst, Marius Opstrup & Thingholm, Peter Rønø, 2022. "Sibling Spillovers and the Choice to Get Vaccinated: Evidence from a Regression Discontinuity Design," IZA Discussion Papers 15109, Institute of Labor Economics (IZA).
    14. Xinyan Shi, 2013. "Information disclosure and vaccination externalities," International Journal of Economic Theory, The International Society for Economic Theory, vol. 9(3), pages 229-243, September.
    15. Celidoni, Martina & Costa-Font, Joan & Salmasi, Luca, 2023. "Mobility Restrictions and Alcohol Use during Lockdown: 'A Still and Dry Pandemic for the Many'?," IZA Discussion Papers 16251, Institute of Labor Economics (IZA).
    16. Joseph Cook & Marc Jeuland & Brian Maskery & Donald Lauria & Dipika Sur & John Clemens & Dale Whittington, 2009. "Using private demand studies to calculate socially optimal vaccine subsidies in developing countries," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 28(1), pages 6-28.
    17. Oster, Emily, 2018. "Does disease cause vaccination? Disease outbreaks and vaccination response," Journal of Health Economics, Elsevier, vol. 57(C), pages 90-101.
    18. Adida, Elodie & Dey, Debabrata & Mamani, Hamed, 2013. "Operational issues and network effects in vaccine markets," European Journal of Operational Research, Elsevier, vol. 231(2), pages 414-427.
    19. Skatun, John Douglas, 2003. "The overprovision of infectious disease medicine," Economics Letters, Elsevier, vol. 80(1), pages 61-66, July.
    20. Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wsi:acsxxx:v:18:y:2015:i:07n08:n:s0219525915500216. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Tai Tone Lim (email available below). General contact details of provider: http://www.worldscinet.com/acs/acs.shtml .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.